Hematology NewsHow to recognize pediatric leukemia cutisJuly 18, 2019AMLLeukemia, Myelodysplasia, TransplantationNonmelanoma Skin Cancer
Hematology NewsADMIRAL results solidify gilteritinib as new standard for FLT3-mutated AMLJune 27, 2019AMLLeukemia, Myelodysplasia, Transplantation
Hematology NewsGuadecitabine offers limited advantage over other standards for high-risk AMLJune 26, 2019AMLLeukemia, Myelodysplasia, Transplantation
Hematology NewsRisk model could help predict VTE in acute leukemiaJune 26, 2019ThrombosisPatient & Survivor CareLeukemia, Myelodysplasia, TransplantationAML
Hematology NewsAML variants before transplant signal need for aggressive therapyJune 25, 2019AMLTransplantLeukemia, Myelodysplasia, Transplantation
Hematology NewsFor tough AML, half respond to selinexor plus chemotherapyJune 25, 2019AMLLeukemia, Myelodysplasia, Transplantation
Hematology NewsAntibody targeting ‘do not eat me’ signals is active in AML, MDSJune 11, 2019AMLMyelodysplastic SyndromeLeukemia, Myelodysplasia, Transplantation
Hematology NewsCombo produces ‘best response rate’ after first relapse in kids with AMLJune 1, 2019AMLPediatricsLeukemia, Myelodysplasia, Transplantation
Hematology NewsFDA panel not ready to recommend quizartinib approval for FLT3-ITD+ AMLMay 14, 2019AMLLeukemia, Myelodysplasia, Transplantation
Hematology NewsMaster trial seeks to aid drug development for pediatric AMLMay 12, 2019AMLLeukemia, Myelodysplasia, TransplantationPediatrics
Hematology TimesResearchers propose new risk groups for NK-AMLMay 8, 2019AMLLeukemia, Myelodysplasia, TransplantationRare Diseases
Hematology TimesCombo proves most effective in HMA-naive, higher-risk MDSMay 3, 2019Myelodysplastic SyndromeLeukemia, Myelodysplasia, TransplantationAML
Hematology NewsFDA approves ivosidenib frontline for certain AML patientsMay 3, 2019AMLLeukemia, Myelodysplasia, TransplantationRare Diseases
Hematology TimesSorafenib plus GCLAM held safe in AML, MDS phase-1 studyApril 22, 2019Leukemia, Myelodysplasia, TransplantationAMLMyelodysplastic Syndrome
Hematology TimesStudy highlights lack of data on transgender leukemia patientsApril 19, 2019AMLLeukemia, Myelodysplasia, TransplantationPatient & Survivor Care
